Nextgen - Asset Resilience Ratio

Latest as of June 2023: 0.12%

Nextgen (NXGN) has an Asset Resilience Ratio of 0.12% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Nextgen to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

ILA15.00K
≈ $40.21 USD Cash + Short-term Investments

Total Assets

ILA12.82 Million
≈ $34.36K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2020)

This chart shows how Nextgen's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NXGN current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Nextgen's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Nextgen carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ILA0.00 0%
Short-term Investments ILA15.00K 0.12%
Total Liquid Assets ILA15.00K 0.12%

Asset Resilience Insights

  • Limited Liquidity: Nextgen maintains only 0.12% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Nextgen Industry Peers by Asset Resilience Ratio

Compare Nextgen's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
Medical Instruments & Supplies 9.87%
Andon Health Co Ltd
SHE:002432
Medical Instruments & Supplies 18.11%
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
Visco Vision Inc.
TW:6782
Medical Instruments & Supplies 0.98%
QITIAN Technology Group Co Ltd
SHE:300061
Medical Instruments & Supplies 0.00%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Interojo Inc
KQ:119610
Medical Instruments & Supplies 6.55%

Annual Asset Resilience Ratio for Nextgen (2019–2020)

The table below shows the annual Asset Resilience Ratio data for Nextgen.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2020-12-31 0.23% ILA19.00K
≈ $50.94
ILA8.32 Million
≈ $22.31K
-0.75pp
2019-12-31 0.98% ILA19.00K
≈ $50.94
ILA1.93 Million
≈ $5.18K
--
pp = percentage points

About Nextgen

TA:NXGN Israel Medical Instruments & Supplies
Market Cap
$1.32 Million
ILA490.55 Million ILA
Market Cap Rank
#30507 Global
#446 in Israel
Share Price
ILA45.00
Change (1 day)
+17.19%
52-Week Range
ILA37.60 - ILA68.40
All Time High
ILA25020.00
About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.